Treatment of Cholelithiasis in Patients With Sickle Cell Anemia
Treatment of Cholelithiasis in Patients With Sickle Cell Anemia
复制标题
镰状细胞性贫血患者胆石症的治疗
DOI：
10.1097/00007611-197904000-00006
复制
发表时间：
1979
影响因子：
1.1
通讯作者：
W. Rambo
中科院分区：
文献类型：
--
作者：
T. J. Gibson;R. O'Dell;R. Cathcart;W. Rambo
对镰状细胞性贫血患者胆石症的发生率和胆囊切除术的手术风险进行了综述。回顾了目前在南卡罗来纳州医科大学血液学诊所就诊的所有镰状细胞病患者的记录。在过去的一年里，口服胆囊造影一直是初步评估的一部分。本文回顾了1968 ~ 1977年间16例胆囊切除术病人的诊断、术前准备、并发症和死亡率。当胆囊的状态是已知的，胆石症的发病率是67%。择期胆囊切除术的发病率高（37%），有一个死亡。不推荐对无症状的胆结石进行胆道镜检查，因为这些患者的手术风险相对较低，预期寿命较短。
The incidence of cholelithiasis and surgical risk of cholecystectomy in patients with sickle cell anemia is reviewed. Records of all patients with sickle cell disease currently attending the Medical University of South Carolina Hematology Clinic were reviewed. An oral cholecystogram has been part of the initial evaluation for the past year. The records of 16 patients having cholecystectomy from 1968 to 1977 were reviewed with regard to diagnostic studies, preoperative preparation, morbidity, and mortality. When the status of the gallbladder is known, the incidence of cholelithiasis is 67%. The morbidity of elective cholecystectomy was high (37%); there was one death. Cholecystectomy is not recommended for the discovery of asymptomatic gallstones because of the relatively poor surgical risk and short life expectancy of these patients.